Position in RLYB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$512,752
+$194,991 QoQ
Shares Held
32,047
-9.5% QoQ
Ownership
0.603%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 37 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLYB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. RLYB ranks #357 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in RLYB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $512,752 | 32,047 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $317,761 | 35,425 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $170,131 | 248,005 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $122,259 | 245,009 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $82,812 | 245,009 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $162,146 | 247,552 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $237,912 | 247,827 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $286,633 | 244,986 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $294,807 | 220,006 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $961,348 | 519,648 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,207,573 | 505,261 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,679,115 | 498,254 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,792,479 | 493,371 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,077,069 | 363,760 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,964,935 | 299,077 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,787,059 | 261,718 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,463,242 | 193,807 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,528,829 | 219,030 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,087,951 | 114,041 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,229,949 | 69,963 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||